Unknown

Dataset Information

0

The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data.


ABSTRACT:

Background

Common variable immunodeficiency disorders (CVID) are a group of rare innate disorders characterized by specific antibody deficiency and increased rates of infections, comorbidities and mortality. The burden of CVID in Europe has not been previously estimated. We performed a retrospective analysis of the European Society for Immunodeficiencies (ESID) registry data on the subset of patients classified by their immunologist as CVID and treated between 2004 and 2014. The registered deaths and comorbidities were used to calculate the annual average age-standardized rates of Years of Life Lost to premature death (YLL), Years Lost to Disability (YLD) and Disability Adjusted Life Years (DALY=YLL?+?YLD). These outcomes were expressed as a rate per 105 of the CVID cohort (the individual disease burden), and of the general population (the societal disease burden).

Results

Data of 2700 patients from 23 countries were analysed. Annual comorbidity rates: bronchiectasis, 21.9%; autoimmunity, 23.2%; digestive disorders, 15.6%; solid cancers, 5.5%; lymphoma, 3.8%, exceeded the prevalence in the general population by a factor of 34.0, 7.6, 8.1, 2.4 and 32.6, respectively. The comorbidities of CVID caused 8722 (6069; 12,363) YLD/105 in this cohort, whereas 44% of disability burden was attributable to infections and bronchiectasis. The total individual burden of CVID was 36,785 (33,078, 41,380) DALY/105. With estimated CVID prevalence of ~?1/ 25,000, the societal burden of CVID ensued 1.5 (1.3, 1.7) DALY/105 of the general population. In exploratory analysis, increased mortality was associated with solid tumor, HR (95% CI): 2.69 (1.10; 6.57) p?=?0.030, lymphoma: 5.48 (2.36; 12.71) p?ConclusionsWhile the societal burden of CVID may seem moderate, it is severe to the individual patient. Delay in CVID diagnosis may constitute a modifiable risk factor of serious comorbidities and death but showed no improvement. Tools supporting timely CVID diagnosis should be developed with high priority.

SUBMITTER: Odnoletkova I 

PROVIDER: S-EPMC6233554 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data.

Odnoletkova Irina I   Kindle Gerhard G   Quinti Isabella I   Grimbacher Bodo B   Knerr Viviane V   Gathmann Benjamin B   Ehl Stephan S   Mahlaoui Nizar N   Van Wilder Philippe P   Bogaerts Kris K   de Vries Esther E  

Orphanet journal of rare diseases 20181112 1


<h4>Background</h4>Common variable immunodeficiency disorders (CVID) are a group of rare innate disorders characterized by specific antibody deficiency and increased rates of infections, comorbidities and mortality. The burden of CVID in Europe has not been previously estimated. We performed a retrospective analysis of the European Society for Immunodeficiencies (ESID) registry data on the subset of patients classified by their immunologist as CVID and treated between 2004 and 2014. The register  ...[more]

Similar Datasets

| S-EPMC7059194 | biostudies-literature
| S-EPMC4479182 | biostudies-literature
| S-EPMC8310859 | biostudies-literature
2015-09-02 | GSE72625 | GEO
2015-09-02 | E-GEOD-72625 | biostudies-arrayexpress
| S-EPMC3731765 | biostudies-literature
2009-07-30 | GSE17269 | GEO
2009-07-30 | E-GEOD-17269 | biostudies-arrayexpress
| S-EPMC6882918 | biostudies-literature
2022-11-03 | GSE207243 | GEO